Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Riemser Arzneimittel, a German pharmaceutical company, has purchased the worldwide specialty dental business of Curasan, including its three leading products, Cerasorb, EpiGuide and Revois.
Subscribe to our email newsletter
Curasan, based in Research Triangle Park, North Carolina, which had been marketing the family of bone regeneration and membrane products in the US since 2004, will now be operating as Riemser.
Rick Patton, vice president of sales at Riemser, said: “We are excited about the recent Riemser acquisition because this will give us the ability to expand our products to our audience of oral surgeons, periodontists, and implantology specialists.”